Characterizing the mesencephalon using susceptibility-weighted imaging.
about
Feasibility of using ultra-high field (7 T) MRI for clinical surgical targetingAutomated segmentation of the substantia nigra, subthalamic nucleus and red nucleus in 7T data at young and old age.Genetic variation in FGF20 modulates hippocampal biologyDirect visualization of the subthalamic nucleus and its iron distribution using high-resolution susceptibility mapping.Serum cholesterol and nigrostriatal R2* values in Parkinson's disease.On the origins of signal variance in FMRI of the human midbrain at high fieldUsing high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system.An assessment of current brain targets for deep brain stimulation surgery with susceptibility-weighted imaging at 7 tesla.Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.Comparison of T2*-weighted and QSM contrasts in Parkinson's disease to visualize the STN with MRIImaging nigral pathology and clinical progression in Parkinson's disease.Magnetic transfer contrast accurately localizes substantia nigra confirmed by histology.The Neuromelanin-related T2* Contrast in Postmortem Human Substantia Nigra with 7T MRIMRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods.Magnetic Resonance Imaging (MRI) in Parkinson's Disease.Red nucleus degeneration in hypertrophic olivary degeneration after pediatric posterior fossa tumor resection: use of susceptibility-weighted imaging (SWI).Novel Pattern of Iron Deposition in the Fascicula Nigrale in Patients with Parkinson's Disease: A Pilot StudySusceptibility-weighted imaging of the venous networks around the brain stem.High-resolution 3-dimensional T2*-weighted angiography (HR 3-D SWAN): an optimized 3-T magnetic resonance imaging sequence for targeting the subthalamic nucleus.Characterizing the contrast of white matter and grey matter in high-resolution phase difference enhanced imaging of human brain at 3.0 T.Localization of the subthalamic nucleus: optimization with susceptibility-weighted phase MR imaging.Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease.Comparison of 3D FLAIR, 2D FLAIR, and 2D T2-weighted MR imaging of brain stem anatomy.Visualization of the internal globus pallidus: sequence and orientation for deep brain stimulation using a standard installation protocol at 3.0 Tesla.
P2860
Q28729904-3E19E62C-0C63-426A-84BC-DC5A25B59D34Q31110984-A7F809EA-F525-41E4-BBDE-BFA2347A7F06Q34018828-9DEB5DB9-0ECF-4E50-8E15-180CD34A5B7AQ34024251-C4CC2977-BBED-4D82-A774-FCD04E780F23Q34243731-717E0B64-8ECD-497B-8D72-5820CEF911BDQ34712173-00577B47-38B3-4B2F-BCB3-14F4D1D33B5AQ34792120-06D0EEBC-68D8-4778-BED4-E4131C3D2FB1Q35072905-CCF9EB10-829E-40A2-8350-2E4F655DA37BQ36243568-DD0E0FA8-CE48-4DDB-9C72-58AE211F21A3Q36350945-89BFFFCA-E274-4FA1-9205-5FA6C6F310D5Q36434577-C0B086AA-2E14-451D-A913-B617496A2D0BQ36501346-71F71D00-5C89-409F-98CF-6FEA229CBDE3Q37232653-5BBD3AAB-ECBD-44FD-A80D-8463D6FC3390Q37370641-CB6C40D2-9CE7-4039-BC6F-4307DF303E2BQ38281082-E0A0D0F2-00FA-49EA-B69F-C8636BA0CFECQ39667730-02085484-994A-4FBF-ADC9-634C4ADA13FDQ42416323-02E14C44-6540-4863-B1CD-81A806E9EEE2Q43583903-87764608-A7D5-426D-9420-7210D4B1C9E0Q44701473-8D4D0266-D2CB-47FD-BD59-61D43319108DQ48456702-5D845325-52DE-475A-8A62-3ADEA7FF9A78Q48579307-857976CB-1E08-46CF-AAA4-28E1A34C2E6FQ48639223-B16949F0-0DC8-4AAC-8822-40B838B1D231Q48696802-1E2E700A-5D97-44AF-89CF-9391AD5C6A7BQ48783246-271155CE-AA29-4088-9A2C-8BDE20E87DBA
P2860
Characterizing the mesencephalon using susceptibility-weighted imaging.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterizing the mesencephalon using susceptibility-weighted imaging.
@en
Characterizing the mesencephalon using susceptibility-weighted imaging.
@nl
type
label
Characterizing the mesencephalon using susceptibility-weighted imaging.
@en
Characterizing the mesencephalon using susceptibility-weighted imaging.
@nl
prefLabel
Characterizing the mesencephalon using susceptibility-weighted imaging.
@en
Characterizing the mesencephalon using susceptibility-weighted imaging.
@nl
P2093
P2860
P356
P1476
Characterizing the mesencephalon using susceptibility-weighted imaging.
@en
P2093
A S Boikov
E M Haacke
E S Manova
W M Kirsch
P2860
P304
P356
10.3174/AJNR.A1401
P577
2008-12-26T00:00:00Z